| CTRI Number |
CTRI/2026/01/100609 [Registered on: 08/01/2026] Trial Registered Prospectively |
| Last Modified On: |
08/01/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Medical Device |
| Study Design |
Non-randomized, Active Controlled Trial |
|
Public Title of Study
|
A study comparing skin treatment using pricking with tiny needles alone and pricking with tiny needles plus insulin application to improve acne scars in patients. |
|
Scientific Title of Study
|
Comparing the Efficacy of Microneedling alone and Microneedling with Topical Insulin among post Acne scars patients in a Tertiary care Hospital - A Non-randomized control trail |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Nethra J |
| Designation |
First year residency |
| Affiliation |
Kirupanandha variyar medical college and Hospital |
| Address |
PG Room, Department of DVL,
Vinayaga mission, chinnasiragapadi, Salem.
Salem TAMIL NADU 636308 India |
| Phone |
9629636954 |
| Fax |
|
| Email |
dr.nethrajai@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr.Seethalakshmi |
| Designation |
Head of the Department of DVL |
| Affiliation |
Kirupanandha variyar medical college and Hospital |
| Address |
Department of DVL,
Vinayaga mission, chinnasiragapadi, Salem.
Salem TAMIL NADU 636308 India |
| Phone |
9843466486 |
| Fax |
|
| Email |
dr.seethalakshmiyadav@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Nethra J |
| Designation |
First year residency |
| Affiliation |
Kirupanandha variyar medical college and Hospital |
| Address |
PG Room, Department of DVL,
Vinayaga mission, chinnasiragapadi, Salem.
Salem TAMIL NADU 636308 India |
| Phone |
9629636954 |
| Fax |
|
| Email |
dr.nethrajai@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
self |
| Address |
PG Room, Department of DVL, Chinnasiragapadi,Salem. |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Nethra |
Vinayaka Missions Kirupananda Variyar Medical College and Hospital |
Chinna Seeragapadi, Salem – 636 308, Tamil Nadu India · Salem TAMIL NADU |
9629636954
dr.nethrajai@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethical committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: L708||Other acne, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
microneedling alone |
Microneedling performed using dermapen (depth 1.5–2.5 mm based on scar type), three sessions at four-week intervals, without any topical adjuvant. |
| Intervention |
Microneedling with topical insulin |
Microneedling performed using dermapen (depth 1.5–2.5 mm based on scar type), followed immediately by topical application of regular insulin (1 unit diluted in 1 mL normal saline), three sessions at four-week intervals. |
|
|
Inclusion Criteria
|
| Age From |
15.00 Year(s) |
| Age To |
45.00 Year(s) |
| Gender |
Both |
| Details |
1.Adults aged 18–45 years
2.Patients with atrophic post-acne scars
3.Willingness to provide informed consent and comply with follow-up |
|
| ExclusionCriteria |
| Details |
Age below eighteen years
Active acne or rosacea or eczema or any facial dermatoses
History of keloid formation
History of bleeding disorders
Hypersensitivity to lignocaine or insulin
Immunocompromised patients
Unrealistically high expectations
Pregnant or lactating women
History of herpes labialis or active herpes infection
Patients who have received isotretinoin therapy within the past six months
Use of chemical peels or laser treatments within the past four week |
|
|
Method of Generating Random Sequence
|
Other |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Improvement in post acne scar severity assessed using goodman and baron qualitative and quantitative scar grading systems |
4 weeks
8 weeks
12 weeks |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1.Patient satisfaction score assessed using Likert scale.
2.Pain assessment using Visual Analogue Scale (VAS).
3.Quality of life assessment using Dermatology Life Quality Index (DLQI) |
1.12 weeks
2.Immediately after each sessions.
3.Baseline and 12 weeks |
|
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
30/01/2026 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Yet Recruiting |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
This study is a non randomized active controlled trial conducted in a tertiary care hospital to compare microneedling alone with microneedling combined with topical insulin. Fifty patients aged 18 to 45 years with atrophic post acne scars will be enrolled and allocated into two groups. Patients will receive three treatment sessions at four week intervals. Clinical outcomes will be assessed using Goodman and Baron scar grading systems along with patient satisfaction and quality of life measures. |